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Abstract 
BACKGROUND: Obese children and adolescents are more prone to have metabolic syndrome (MS).MS is a 
cluster of cardiovascular risk factors associated with insulin resistance. Body round index [BRI], visceral adiposity 
index [VAI] and a body shape index [ABSI] are among the new obesity anthropometric parameters. 
AIM: To evaluate the new markers for obesity in children and their possible association with other laboratory and 
clinical variables of MS. 
METHODS: Eighty nine obese children and 40 controls aged 10-18 years were recruited. Full history taking, 
thorough clinical examination, anthropometric and biochemical features were performed in the studied groups. 
Subcutaneous fat thickness (SFT) and visceral fat thickness (VFT) were estimated by ultrasonography. 
RESULTS: Obese children, exhibited significantly higher values in all anthropometric measurements (P < 0.001). 
Diastolic and systolic blood pressure were significantly higher (P < 0.001) in the obese group. ABSI, BRI and VAI 
have been found to be significantly higher in obese subjects (P < 0.001), with no significant gender difference. 
BMI, WHtR, WC/HR, SBP, DBP, subcutaneous fat thickness and visceral fat thickness, Liver Span, ABSI, BRI, 
VAI and HOMA_IR were significantly higher among children with MS than those without MS. Positive significant 
correlations of VAI with BMI, WC/Ht, WC/Hip, SBP, DBP, SFT, VFT, Liver size and HOMA-IR (r = 0.384, 0.239, 
0.268, 0.329, 0.516, 0.320, 0.254, 0.251, and 0.278 respectively) are shown. The area under the ROC curve 
(AUC) of BMI, VAI, ABSI, BRI for predicting MS was 0.802 (0.701-0.902), 0.737 (0.33-0.841), 0.737 (0.620-
0.855), 0.816 (0.698-0.934). 
CONCLUSION: We suggest using the VAI and WHtR indexes, as they are better predictor of MS. 
 
 
 
Introduction 
 
Obesity in young populations is on the 
increase due to changes in nutrition behaviors and 
lifestyle. In Egypt, obese subjects represented about 
15.6 % of adolescents aged 10-19 in 2017. Egypt is 
predicted to rank as the sixth country suffering of 
having high number of obese subjects (6,818,532) 
aged 5-19 years in 2030 [1], [2]. 
Obese children and obese adolescents are 
also more prone to have hyperlipidemia, hypertension, 
type 2 diabetes and metabolic syndrome (MS). The 
widespread of obesity among children, leads to the 
increased occurrence of MS in them. The metabolic 
syndrome has been reported in young populations in 
Egypt and other countries [3], [4]. Several authors 
have reported the prevalence of the metabolic 
syndrome in children [5], [6]. There is no consensus 
about the definition of MS in children [7]. Magge et al., 
reported that focusing on the screening and treating 
the individual risk factor components of MS and cardio 
metabolic risk factor was emphasized over the need 
to define a pediatric MS [8]. 
The most commonly used criteria in different 
studies are the modified WHO, Cook and the IDF 
consensus criteria [9], [10]. MS is a cluster of 
cardiovascular risk factors associated with insulin 
resistance and are driven by several factors, including 
visceral obesity [11]. 
The body mass index (BMI) is a good index to 
diagnose general obesity, but it does not reflect fat 
distribution or differentiate muscle and fat masses. 
Waist circumference (WC) has been suggested as an 
alternative to BMI. It is a parameter of abdominal 
obesity. However, many studies have showed that 
WC is highly correlated to BMI; so, its value per se is 
limited. To solve these problems, new anthropometric 
parameters were developed [12]. Efforts should be 
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made for recognition of this metabolic risk. 
Among the new obesity anthropometric 
parameters (body round index [BRI], visceral adiposity 
index [VAI]) and a body shape index [ABSI], were 
found to be significantly associated with arterial 
stiffness in adult [13]. 
The visceral adiposity index (VAI), is a sex-
specific indicator of visceral fat distribution which 
depends on BMI, WC, triglyceride and high-density 
lipoprotein-cholesterol (HDL-C) [14]. 
A body shape index (ABSI), using a 
standardized WC based on BMI and height, reflects 
mortality hazard better than BMI and WC [15]. While, 
the body roundness index (BRI), is an indicator of 
body fat and visceral adipose tissue percentage, and 
may be useful for evaluating health status [15]. 
To the best of our knowledge, no study 
analyzing the cross-sectional relationships between 
these new anthropometric parameters, obesity ,blood 
pressure, insulin resistance, and other markers of the 
MS in childhood. The present study aimed to evaluate 
these new parameters of obesity in children and their 
possible association with other laboratory and clinical 
variables of MS. 
  
 
Materials and Methods 
 
Study Population  
We performed a cross-sectional study. The 
study protocol was approved by the Human Ethics 
Committee of National Research Center, and written 
informed consent was obtained from children's 
caregivers (Approval No14019 ) . We enrolled 89 
obese children (30 male, 59 female); they were 
attending the Pediatrics Obesity Clinic in Centre of 
Excellence in National Research Centre, with age 
range from 10 to 18 years. A child was obese if BMI > 
95th percentile for age and gender percentile curves 
of growth for our population [16]. 
The obese subjects were divided into two 
groups: first group included patients with metabolic 
syndrome. We used the IDF definition of MS for 
children aged 10 years or older which includes 
BMI>90th percentile for age and sex and presence of 
two or more of the following findings: (1) triglycerides 
>150 mg/dl; (2) HDL-cholesterol <40 mg/dl; (3) 
systolic blood pressure >130 mmHg, diastolic >85 
mmHg; and (4) fasting plasma glucose >100 mg/dl or 
known type 2 diabetes [14], a second group includes 
patients without MS. 
Exclusion criteria: medical conditions 
associated with obesity such as cardiac, hepatic or 
renal diseases, hypothyroidism, Cushing syndrome or 
Turner syndrome, also obesity with mental 
retardation, such as Prader-Willi syndrome, Laurence-
Moon- Biedl and Cohen syndrome. 
A control group included 40 children (25 male, 
15 female); they were age-matched healthy subjects. 
 
Clinical Examination 
The following were performed on the studied 
groups: 
1) Full history taking through clinical 
examination, with emphasis on any complications or 
medication; 2) Blood pressure was measured 
according to American Heart Association guidelines; 
three times for patients and controls after 5-min rest in 
sitting position with the use of mercury 
sphygmomanometer. The mean value of 2nd and 3rd 
measurement was calculated. SBP was defined as 
the onset of the Korotkoff sound (K1), and DBP was 
defined as the fifth Korotkoff sound (K5); and 3) 
Anthropometric indices: Body weight measured to the 
nearest 0.1 kg with a balance scale and height 
measured to the nearest 0.1 cm. Body mass index 
was calculated as weight divided by height squared 
(kg/m2). Waist circumference (WC) was measured at 
the level midway between the lowest rib margin and 
the iliac crest. Hip circumference (HIP C) was 
measured at the widest level over the greater 
trochanters in a standing position by the same 
examiner; then waist to hip ratio (WHR) and Waist to 
height ratio (WHtR) were calculated. 
Among the new obesity anthropometric 
parameters: body round index (BRI), and visceral 
adiposity index (VAI) and a body shape index (ABSI) 
were calculated by the following equations [9]. 
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TG, and HDL-C levels are expressed in 
mmol/L, and WC in expressed in cm [9], [13]. 
 
Abdominal Ultrasonography 
In addition to the routine abdominal 
ultrasound examination based on the clinical 
indication, ultrasonography (US) distinctively 
quantifies visceral fat and subcutaneous fat. We 
measured the maximum pre peritoneal visceral fat 
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thickness (VFT) and the minimum subcutaneous fat 
thickness (SFT) by US. The visceral fat thickness 
(VFT) was measured by 3.5-5 MHz convex-array 
probe. VFT is the distance between the internal 
surface of the abdominal surface of abdominal muscle 
and the anterior wall of the aorta 1 cm above the 
umbilicus. The thickness of subcutaneous fat was 
measured by placement of a 3.75-MHz probe 
perpendicular to the skin on the epigastrium. 
Longitudinal scans are obtained along the middle line 
(linea Alba). The thickness of the subcutaneous fat is 
defined as the distance between the anterior surface 
of linea Alba and the fat-skin barrier [17], [18]. 
Ultrasound apparatus model is SA –R3 (No S06YM3 
HDC00012F) SAMSUNG MEDISON Company –
South Korea. 
 
Laboratory measurements 
Ten millimeters of venous blood were 
withdrawn under complete aseptic precautions from 
fasting subjects (12-14 hrs.). Samples were labeled 
and left to clot at room temperature for 15 min then 
centrifuged, sera were collected and aliquoted for 
evaluation of the following parameters: 1) 
Determination of complete lipid profile (serum 
triglycerides, HDL, LDL cholesterol) was done using 
colorimetric methods on Olympus AU 400 supplied 
from Olympus Life and Material Science (Europe 
GmbH, Wendenstraße, Hamburg, Germany); 2) 
Fasting blood glucose was assessed using Hitachi 
912 chemistry analyzer (Roche Diagnostics GmbH, D-
68298 Mannheim, Germany) by colorimetric 
techniques; 3) Insulin levels were estimated by 
Enzyme immunoassay (ELISA); 4) Insulin resistance 
was calculated by the homeostasis model (HOMA-IR) 
using the following formula: HOMA-IR = fasting insulin 
(mU/L) × fasting glucose (mmoL/L)/22.5; and 5) 
Glycosylated Hb (HbA1c) was measured using ion 
exchange HPLC (high performance liquid 
chromatography) Kit supplied by Crystal Chem, USA. 
 
Statistical analysis 
The standard computer program Statistical 
Package for the Social Sciences (SPSS) for Windows, 
release 17.0 (SPSS Inc., USA) was used for data 
entry and analysis. All numeric variables were 
expressed as mean ± standard deviation (SD). 
Comparison between groups was made using Student 
t test for continuous variables and Chi-Square tests 
for categorical variables. Pearson's and Spearman's 
correlation tests (r = correlation coefficient) were used 
for correlating normal and non-parametric variables 
respectively. The receiver operating characteristic 
(ROC) curve was generated to detect the predictive 
capabilities of BMI, ABSI, BRI, VAI for MS. P < 0.05 
was considered statistically significant. 
 
Results 
 
There were no significant differences between 
obese subjects (with & without MS) and control 
groups in terms of age (p > 0.05). Obese children -the 
characteristics of the three subgroups are included in 
Table 1, and Table 2. Regarding clinical data, Table 1 
revealed statistically significant difference between 
studied groups in BMI , WC, WHtR , Systolic BP and 
Diastolic BP (P = 0.000, 0.000, 0.000, < 0.001 & 
0.000, respectively) . Also other measurements by 
abdominal ultrasonography (SFT, VFT & liver size) 
showed same results (P = 0.000, 0.002, 0.000, 
respectively). 
Table 1: Characteristics of the studied population 
Item Subgroups N Mean 
Std. 
Deviation 
ANOVA 
SIG 
Age Years 
 
No MS 67 11.449 2.6169 
0.432 MS 22 11.923 2.7526 
Controls 40 10.65 4.3597 
BMI (kg/m2) 
No MS 67 24.1227 8.56 
0.000 MS 22 38.2623 6.63 
Controls 40 17.92 4.17 
WC CM 
  
No MS 67 78.6753 22.19 
0.000 MS 22 104.8462 11.68 
Controls 40 69.68 18.56 
WHtR  
  
No MS 67 0.469 0.16 
0.699 MS 22 0.5877 0.10 
Controls 40 0.46 0.08 
  
WHtR 
No MS 67 0.55 0.15 
0.000 MS 22 0.77 0.10 
Controls 40 0.43 0.11 
Systolic BP 
 
No MS 67 95.01 19.87 
0.001 MS 22 117.08 12.51 
Controls 40 89.74 16.97 
Diastolic BP 
No MS 67 63.82 8.381 
0.000 MS 22 77.92 10.544 
Controls 40 61.67 8.683 
SFT [cm] 
No MS 67 1.53 0.74 
0.000 MS 22 2.70 0.68 
Controls 40 1.29 0.50 
VFT [cm] 
No MS 67 3.44 1.51 
0.002 MS 22 4.83 1.66 
Controls 40 2.53 o.93 
Liver Size CM 
No MS 67 13.00 1.88 
0.000 
 
MS 22 15.75 1.07 
Controls 40 11.39 1.90 
No MS = No metabolic syndrome; MS = Metabolic Syndrome; (SBP) Systolic blood pressure; (DBP) diastolic 
blood pressure; (SFT), subcutaneous fat thickness; (VFT) visceral fat thickness; (WC) Waist circumference; 
(BMI) Body mass index; (WHtR) Waist to height ratio; (WHR) waist to hip ratio. 
 
In the studied groups, our laboratory 
parameters data exhibited significant difference in 
HOMA-IR values, fasting insulin, HDL & LDL (P = 
0.000, 0.028, 0.003, 0.004). Further details are in 
Table 2. 
Table 2: Laboratory results of the studied population 
Item Subgroups N Mean Std. Deviation ANOVA SIG 
FBG [mg/dl] 
No MS 67 82.00 28.23 
0.986 MS 22 83.23 14.26 
Controls 40 81.47 10.92 
HOMA_IR 
No MS 67 2.47 1.70 
0.000 MS 22 4.48 1.309 
Controls 40 2.19 1.517 
HgA1C 
No MS 67 5.65 0.610 
0.315 MS 22 5.95 0.777 
Controls 40 5.77 0.617 
Fasting 
Insulin [mU/l] 
No MS 67 13.86 9.079 
0.028 MS 22 21.72 4.362 
Controls 40 12.86 11.536 
Cholesterol 
[mg/dl]  
No MS 67 157.78 30.68 
0.064 MS 22 176.15 38.71 
Controls 40 161.47 36.54 
Triglycerides 
[mg/dl] 
No MS 67 88.59 32.00 
0.143 MS 22 108.15 46.32 
Controls 40 84.23 28.24 
HDL [mg/dl] 
No MS 67 53.37 15.90 
0.003 MS 22 37.61 10.79 
Controls 40 54.42 14.21 
LDL [mg/dl] 
No MS 67 86.14 29.55 
.004 
 
MS 22 116.84 36.35 
Controls 40 101.27 33.89 
No MS = No metabolic syndrome; MS = Metabolic Syndrome; FBG = Fasting blood 
glucose; HOMA-IR = the homeostasis model assessment; HDL = High-density lipoprotein; 
LDL = Low-density lipoprotein, HbA1C Glycosylated Hb. 
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Among the new obesity indices, ABSI, BRI 
and VAI have been found to be significantly higher in 
obese subjects (P < 0.001) (Table 3). Additionally, we 
found no significant gender difference in all studied 
items. 
Tabe 3: New anthropometric parameters of obese& non-obese 
children 
Item  Group N Mean Std. Deviation Sig. (2-tailed)  
ABSI Controls 40 7.58 1.31 0.001 
 Obese 89 5.49 3.02 
BRI Controls 40 4.28 2.28 0.001 
 Obese 89 9.14 8.29 
VAI Controls 39 1.63 0.95 0.001 
 Obese 89 3.41 3.03 
(ABSI) a body shape index; ( BRI) body round index; (VAI) visceral adiposity index. 
 
In addition, we found that 24.75% (22 
subjects, 17 females & 5 males) of the obese children 
aged 10-16 years met the criteria for MS based on the 
pediatric MS definition of the IDF consensus. Table 4 
shows the differences between obese with & without 
MS. BMI, WHtR, WC/HipR, SBP, DBP, SFT, VFT, 
Liver Span, ABSI, BRI, VAI and HOMA_IR were 
significantly higher among children with MS than 
those without MS. 
Table 4: Comparison between obese children with & without 
MS 
  N Mean Std. Deviation Sig. (2-tailed) 
ABSI 
Without MS 67 4.79 3.17 0.001 
 With MS 22 7.64 0.52 
BRI 
Without MS 67 8.11 7.38 0.041 
 With MS 22 12.26 10.16 
VAI 
Without MS 67 2.42 1.95 0.001 
 With MS 22 6.43 3.71 
BMI (kg/m2) 
Without MS 67 31.90 5.92 0.001 
 With MS 22 38.61 5.85 
WC cm 
Without MS 67 92.80 11.07 
0.001 
With MS 22 104.72 11.39 
Whtr 
Without MS 67 0.61 0.13 0.005 
 With MS 22 0.70 0.08 
WHR 
Without MS 67 0.67 0.12 0.002 
 With MS 22 0.76 0.11 
Systolic BP mm Hg 
Without MS 67 105.85 10.50 0.001 
 With MS 22 116.25 11.57 
Diastolic BP mm Hg 
Without MS 67 67.36 8.24 0.001 
 With MS 22 80.25 9.10 
HOMA_IR 
Without MS 67 2.83 1.69 0.001 
 With MS 22 4.53 1.20 
SFT cm 
Without MS 67 2.12 0.57 0.001 
 With MS 22 2.91 0.92 
VFT cm 
Without MS 67 4.58 1.28 0.001 
 With MS 22 5.92 1.73 
Liver Span cm 
Without MS 67 14.13 1.64 0.001 
 With MS 22 15.86 1.31 
Triglyceride [mg/dl] 
Without MS 67 90.83 24.06 0.001 
 With MS 22 112.95 47.25 
 HDL [mg/dl] 
Without MS 67 56.01 26.31 0.014 
 With MS 22 41.34 17.99 
(SBP) Systolic blood pressure; (DBP) diastolic blood pressure (SFT); subcutaneous fat 
thickness; (VFT) visceral fat thickness; (WC) Waist circumference; (HDL) High-density 
lipoprotein. 
  
Correlations between ABSI, BRI and VAI and 
the studied variables in obese subjects are shown in 
Table 5. Results showed positive significant 
correlations of VAI with BMI, WC/Ht, WC/Hip, SBP, 
DBP, SET, VFT, Liver size and HOMA-IR (r = 0.384, 
0.239, 0.268, 0.329, 0.516, 0.320, 0.254, 0.251, and 
0.278, respectively). While, BRI had statistically 
significantly positive correlation with BMI, WC/Ht and 
HOMA-IR (r = 0.343, 0.234, and 0.322, respectively). 
ABSI had statistically significantly positive correlation 
with WC/Ht only, (r = 0.220). 
Table 5: Correlations between the studied variables in obese 
subjects 
 BMI WC/ Ht WC/Hip SBP DBP SFT VFT Liver size HOMA-IR 
VAI 
r 0.384** 0.239
*
 0.268
*
 0.329
**
 0.516
**
 0.320
**
 0.254* 0.251
*
 0.278
**
 
P 0.000 0.024 0.012 0.004 0.000 0.004 0.023 0.022 0.008 
ABSI 
r 0.002 0.220
*
 -0.075 0.102 0.163 0.035 0.079 0.036 0.066 
P 0.984 0.039 0.491 0.390 0.169 0.760 0.488 0.747 0.537 
BRI 
r 0.343
**
 0.234
*
 0.181 0.123 0.144 0.097 0.047 0.062 0.322
**
 
P 0.001 0.028 0.093 0.298 0.225 0.395 0.678 0.580 0.002 
**Correlation is significant at the 0.01 level (2-tailed); *correlation is significant at the 0.05 
level. 
The receiver operating characteristic (ROC) 
curve was generated to detect the predictive 
capabilities of BMI, WC/Ht R, WC/Hip R, VAI, ABSI, 
and BRI for predicting MS (Figure 1, and Figure 2).  
  
Figure 1: ROC Curves of BMI, WCHt R and WCHip R (left); ROC 
Curves of ABSI, BRI, and VAI (right) 
 
 The area under the ROC curve (AUC) of BMI, 
VAI, ABSI, BRI for predicting MS was 0.802 (0.701-
0.902), 0.737 (0.633-0.841), 0.737 (0.620-0.855), 
0.816 (0.698-0.934), respectively. Details are in Table 
6. 
Table 6: Area under the curve in obese children of all studied 
variables 
Test Result Variables Area Std. Error Sig. 
Asymptotic 95% Confidence Interval 
Lower Bound Upper Bound 
BMI 
W/HtR 
WHR 
0.802 
0.730 
0.720 
0.051 
0.065 
0.062 
0.000 
0.001 
0.002 
0.701 
0.604 
0.599 
0.902 
0.857 
0.841 
ABSI 0.737 0.053 0.001 0.633 0.841 
BRI 0.737 0.060 0.001 0.620 0.855 
VAI 0.816 0.060 0.000 0.698 0.934 
Null hypothesis: true area = 0.5 & AUC: .90-1 = excellent (A),80-.90 = good (B),.70-.80 = 
fair (C). 
 
 
Discussion 
 
Obesity is responsible for health burden in 
children and adolescents in Egypt and all over the 
world. BMI and WHtR are important indexes for 
predicting obesity and MS. However, Studies from 
South Africa reported that WHtR is the best predictor 
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of MS [19].  
BMI and WHtR are limited in differentiating 
the lean mass from adipose tissue, and are not 
reflecting lipid accumulation in the circulating blood 
[20]. The specific mechanism causing MS has not 
been established, but, central obesity plays a critical 
role. It is hypothesized that an excess visceral 
adipocytes contributes to a pro inflammatory state and 
insulin resistance and involved with the development 
of MS [21], [22]. Ethnic and racial variation might need 
different cutoff points or use of different 
anthropometric measurement to diagnose obesity and 
MS [23]. 
In this study we evaluated and compared old 
and new anthropometric indices for detecting body 
adiposity .Seven anthropometric parameters: BMI, 
WC, WHtR, WHR, VAI, ABSI and BRI were studied. 
Based on our results all anthropometric parameters 
assessed, have been found to be significantly higher 
in obese subjects (P < 0.001) than controls which is in 
accordance with other studies [3]. 
MS cases showed a group of cardiovascular 
risk factors including central obesity (measured by 
high WC or high BMI), high systolic and diastolic 
pressure, high triglycerides, low HDL, high fasting 
glucose and high HOMA-IR. Previous studies showed 
similar results [3],[24]. 
Our results showed, that BMI and WHtR were 
predictive of obesity and MS. However, they did not 
reflect lipid accumulation in the circulating blood 
neither differentiating the lean mass from adipose 
tissue. Therefore, BMI and WHtR were not the best 
predictive indices of obesity and MS. These results 
were in accordance with those of other studies [25], 
[26]. 
In an attempt for searching of the best 
predictor of MS, we evaluated new anthropometric 
parameters of obesity namely; ABSI, BRI,and VAI. 
ABSI showed a significant ability to predict MS in this 
study, ABSI showed significant ability to predict MS. 
ABSI was shown to be a reliable index of fat 
accumulation as it encompasses waist circumference 
and BMI.Previous cross-sectional and prospective 
studies from Iran and china have reported ABSI to be 
a weak predictor of MS [27], [28], [29]. 
 BRI had statistically significantly positive 
correlation with BMI, WHtR and HOMA-IR. 
Our study showed that BRI was predictive of 
MS. However, this result remains controversial. One 
study showed its potential to identify MS andT2 DM, 
[30] whereas another study reported that BRI is not 
better than old obesity parameters in predicting MS 
[31]. 
Recently, visceral adiposity index (VAI) has 
shown promise as a marker of visceral fat dysfunction. 
The VAI is based on sex, body mass index (BMI), 
waist circumference (WC) and metabolic parameters 
(serum triglycerides and [HDL-C] levels. Our study 
showed positive significant correlations of VAI with 
BMI, WC/ Ht, WC/Hip, SBP, DBP, SET, VFT, Liver 
size and HOMA-IR. The VAI showed a strong 
predictive ability of MS better than BMI and WHtR 
according to area under the curve (0.816, 0.802, 
0.730, with P = 0.000, 0.001, 0.002, respectively). 
This result was in accordance with those of other 
studies [32], [33], [34], [28]. Yang et al., reported that 
VAI could be a surrogate index for obesity 
assessment [35]. Our study is strengthened by the 
fact that the VAI was established as an index of 
visceral fat dysfunction. Choi et al showed that the 
new obesity indices, ABSI and VAI have been found 
to be significantly associated with arterial stiffness 
[36]. MS in childhood predicts adult cardiovascular 
disease [37]. MS appears to accelerate the 
cardiovascular disease process [38]. Thus, the VAI is 
very suitable for our subjects. However, there are 
conflicting data in different populations and ethnicity 
groups, regarding MS [39]. Screening for obesity and 
MS should be incorporated in pediatric clinical care 
[40]. 
Limitations in the current study: This study 
was cross-sectional and there was limited ability to 
validate causality between the new markers and MS. 
Studied group was small, and might be insufficient to 
represent MS in children and adolescents. 
In conclusion, the tested anthropometric 
parameters could predict body fat percent with 
relatively good power; however VAI, BMI and WHtR 
indices are more powerful predictors. Based on our 
findings, we suggest using the VAI and WHtR indices 
are better predictors of MS. Additional studies with 
larger obese group are necessary. 
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